Current Immunology Reviews (Discontinued)
Volume 16, 2 Issues, 2020
ISSN: 1875-631X (Online)
ISSN: 1573-3955 (Print)
This journal supports open access
ISSN: 1875-631X (Online)
ISSN: 1573-3955 (Print)
This journal supports open access
Contents
Current Immunology Reviews, Volume 6 - Number 2
Differential Enhancement of T Helper Type 1 (Th1)/Th2 Cytokine Production by Natural Killer T Cells Through Negative Feedback Regulation with Cytokine-conditioned Dendritic Cells
, 6(2): 78 - 87Kazuya Iwabuchi, Yoshiki Yanagawa, Keita Minami, Kazuomi Mizuuchi, Masanori Maeda, Hisako Ogura, Masashi Satoh, Fumie Hayashi, Yoshikuni Obata, Noriko Ikeda, Daiju Iwata, Noriyuki Hirata, Chikako Iwabuchi and Kazunori Onoe
DOI: 10.2174/157339510791111745
Invariant Natural Killer T Cell-Based Therapy of Autoimmune Diseases
, 6(2): 88 - 101Curtis L. Gabriel, Lan Wu, Vrajesh V. Parekh and Luc Van Kaer
DOI: 10.2174/157339510791111682
Application of NKT Cells in Immunotherapy
, 6(2): 109 - 115Yasuyuki Ishii, Shinichiro Motohashi, Kanako Shimizu, Toshinori Nakayama, Masaru Taniguchi and Shin-ichiro Fujii
DOI: 10.2174/157339510791111736
Glycolipid Antigen – Mediated Invariant NKT Cell Activation in Microbial Immunity
, 6(2): 116 - 122Yuki Kinjo and Bo Pei
DOI: 10.2174/157339510791111709
Myeloperoxidase: The Good, the Bad, and the Ugly
, 6(2): 123 - 129Doris L. Lefkowitz, James Mone and Stanley S. Lefkowitz
DOI: 10.2174/157339510791111691
The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells
, 6(2): 130 - 136Gisela Vaitaitis, Dan Waid and David H. Wagner Jr.
DOI: 10.2174/157339510791111673
The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research
, 6(2): 137 - 148Eric N. Momin, Guillermo Vela, Hasan A. Zaidi and Alfredo Quinones-Hinojosa
DOI: 10.2174/157339510791111718
Editor-in-Chief
Cecil Czerkinsky
Institut de Pharmacologie Moleculaire et Cellulaire
UMR 7275 CNRS-INSERM-UNISA
660 Route des Lucioles
Valbonne, 06560
(France)
Biography
Institut de Pharmacologie Moleculaire et Cellulaire
UMR 7275 CNRS-INSERM-UNISA
660 Route des Lucioles
Valbonne, 06560
Biography
Biography of Cecil Czerkinsky
Dr. Czerkinsky is currently Research Director at the Institute of Molecular and Cellular Pharmacology, a research organization spearheaded by the French National Research Council (CNRS), the National Institute of Health and Medical Research (INSERM) and the University of Nice at Sophia Antipolis (France). He previously served as Deputy Director General and Head of R&D at the International Vaccine Institute (Seoul, South Korea) and as Professor at Seoul National University, Korea University, and Göteborg University (Sweden). He has authored more than 180 scientific publications and is an inventor of more than 20 patents in the field of immunology and vaccine science.
Journal History
Current Immunology Reviews Journal was launched in 2005. Dr. Cecil Czerkinsky serves as the Editor-in-Chief of the journal.
New eBook
 |
Immune Response to Parasitic Infections: Immunity to Helminths and Novel Therapeutic ApproachesYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net